News
Aprazer Healthcare Launched INLYBEST
Launch Date: 29/08/20 Aprazer Healthcare Launched INLYBEST (Axitinib) which i...
Aprazer Healthcare Launched OCABEST
Launch Date: 10/08/20 Aprazer Healthcare Launched OCABEST (Obeticholic Acid )...
Aprazer Healthcare Launched Indenza
Launch Date: 13-07-2020 Aprazer Healthcare Launched INDENZA ( ENZULATAMIDE ) which is a medication indicated for the treatment of castration-resistant prostate cancer (CRPC)....
Aprazer Healthcare Launched RIFAXIGEM
Launch Date: 24-06-2020 Aprazer Healthcare Launched Rifaxigem ( Rifaximin) which is a medication indicated for the treatment of IBS with Diarrhea and Hepatic....
Aprazer Healthcare Launched Dasakast
Launch Date: 03-06-2020 Aprazer Healthcare Launched DASAKAST (Dasatinib ) which is a medication used to treat newly diagnosed adults Philadelphia Chromosome -Positive( Ph+ ) Chronic Myeloid....
Aprazer Healthcare Launched ABIRAKAST
Aprazer Healthcare Launched ABIRAKAST (Abiraterone acetate ) which is a medication used to treat prostate cancer specifically it is used together with corticosteroid for .....
Aprazer Healthcare Launched SORAFEKAST
Aprazer Healthcare Launched SORAFEKAST (Sorafenib Tablets ) is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma).....
Aprazer Healthcare Launched Imatikast
Launch Date: 21-12-2019 Aprazer Healthcare Launched IMATIKAST (IMATINIB ) which is a medication used to treat. • Myelodysplastic/Myeloproliferative Diseases.....
Aprazer Healthcare Launched HEPAKAST
Launch Date: 06-12-2019 Aprazer Healthcare Launched HEPAKAST containing l-leucine; l – isoleucine: l-valine. HEPAKAST is a Health Supplement indicated in....
Aprazer Healthcare Launched Sofokast Plus
Aprazer Healthcare Launched under its brand Sofokast Plus, the generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg Tablet, for the treatment of patients....
